Acasă › Leucemie mieloasă acută › Georgia › Atlanta
Studii clinice pentru Leucemie mieloasă acută în Atlanta, GA
31 studii pentru Leucemie mieloasă acută caută participanți în și în jurul orașului Atlanta (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
În curs de recrutareFaza 1
- Children'S Healthcare Of Atlanta - Arthur M. Blank Hospital /ID# 275740, Atlanta
Ivosidenib as Post-HSCT Maintenance for AML
În curs de recrutareFaza 2
- Emory University Hospital, Atlanta
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
În curs de recrutareFaza 1
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
În curs de recrutareFaza 2/3
- Winship Cancer Institute of Emory University /ID# 279006, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Atlanta VA Medical Center, Decatur · La 6 mi distanță
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
În curs de recrutareStudiu observațional
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
În curs de recrutareFaza 1
- Emory University Hospital/Winship Cancer Institute, Atlanta
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
În curs de recrutareFaza 1
- Emory University, Atlanta
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
În curs de recrutareFaza 3
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
În curs de recrutareFaza 1/2
- Emory Winship Cancer Institute, Atlanta
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
În curs de recrutareFaza 2
- Winship Cancer Institute - Emory University, Atlanta
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
În curs de recrutareFaza 3
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
În curs de recrutareFaza 3
- US-Atlanta GA-EMORY, Atlanta
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
În curs de recrutareFaza 3
- US-Atlanta GA-EMORY, Atlanta
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
În curs de recrutareFaza 1/2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
În curs de recrutareFaza 3
- Children's Healthcare of Atlanta, Atlanta
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
În curs de recrutareFaza 1
- Emory Healthcare - The Emory Clinic, Atlanta
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
În curs de recrutareFaza 1
- Children's Healthcare of Atlanta, Atlanta
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
În curs de recrutareFaza 1Voluntari sănătoși bineveniți
- Northside Hospital, Atlanta
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
În curs de recrutareFaza 3
- Emory University - Winship Cancer Institute (WCI), Atlanta
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
În curs de recrutareStudiu observațional
- Children's Healthcare of Atlanta, Atlanta
- Northside Hospital, Atlanta
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
În curs de recrutareFaza 1/2
- Emory Winship Cancer Institute, Atlanta
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
În curs de recrutareFaza 1
- Winship Cancer Institute / Emory University, Atlanta
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
În curs de recrutareFaza 2/3
- University of Emory - Winship Cancer Institute, Atlanta
Pilot Imaging Study of Leukemia
În curs de recrutareFaza 1
- Emory University, Atlanta
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
În curs de recrutareFaza 1
- Emory Healthcare - The Emory Clinic, Atlanta
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
În curs de recrutareFaza 2Voluntari sănătoși bineveniți
- Northside Hospital, Atlanta
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
În curs de recrutareFaza 1
- Emory University Hospital, Atlanta
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
În curs de recrutareFaza 1
- Emory University - WINSHIP Cancer Center, Atlanta
- Emory University, Children's Healthcare of Atlanta, Atlanta
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
În curs de recrutareFaza 1
- Blood and Marrow Transplant Group of Georgia, Atlanta
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
În curs de recrutareVoluntari sănătoși bineveniți
- Emory University, Atlanta
Studii pentru Leucemie mieloasă acută în alte orașe
- Houston, TX85 studii
- New York City, NY51 studii
- Boston, MA44 studii
- Seattle, WA41 studii
- Baldwin Park, CA40 studii
- Columbus, OH35 studii
- Philadelphia, PA34 studii
- Durham, NC33 studii
- Tampa, FL29 studii
- Chicago, IL26 studii
- Portland, OR25 studii
- Washington, DC24 studii
Alte studii în Atlanta
- Cancer (toate tipurile)49 studii
- Cancer pulmonar cu celule non-pătrate47 studii
- Mielom multiplu42 studii
- Cancer de sân41 studii
- Cancer de prostată33 studii
- Cancer ovarian29 studii
- Cancer colorectal29 studii
- Cancer pulmonar29 studii
- Cancer metastatic28 studii
- Tulburare depresivă majoră25 studii
- Insuficiență cardiacă25 studii
- Carcinom cu celule scuamoase de cap și gât24 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.